AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
BUSINESS BRIEFS.(TO THE POINT)
MEDICAL
Regulators delay Merck review
The FDA wants more data showing that experimental arthritis drug Arcoxia, a cox-2 inhibitor like recently withdrawn Merck drug arthritis Vioxx and the drug's successor on the market, is safe and effective. Details of the FDA's request were not released. Arcoxia is sold in Europe, Latin America and Asia, and is expected to generate $1 bil in sales by '08. Shares fell 1% to 31.31.
Beckman Coulter Q3 rises 17.4%
The lab equipment maker earned 74 cents a share ex items, 11 cents over the year-ago profit and 2 cents over views. A 10% rise in clinical diagnostic sales pushed revenue up 8.6% to $581.2 mil. Beckman Coulter forecast 95-97 cents a share in Q4, below views of $1.03, but it steered its '04 forecasts above views to $3.21-$3.27 a share. Shares rose 3% to 59.50.
Generics hit Bristol-Meyers Q3
The drug maker made 44 cents a share ex ...
- SGI and Incyte Deploy Linux Solution for Bioinformatics at Bristol-Myers Squibb.
- Press release article from: PR Newswire November 21, 2000 700+ words
...bioinformatics at Bristol-Myers Squibb. "Some things we do take...developed for the Bristol-Myers Squibb bioinformatics research group integrates Incyte's Linux...solution increases Bristol-Myers Squibb's ability to run analyses...
- Despite Recent Negative Media Coverage Regarding Plavix, Bristol-Myers Squibb...
- Press release article from: PR Newswire June 13, 2007 700+ words
...Resources and Millennium Research Group have produced a new...problems, Bristol-Myers Squibb remains the number...analyst at Millennium Research Group. "However, because...About Millennium Research Group Millennium Research...
- Bristol-Myers Squibb Scientists Named `Heroes of Chemistry'; David Cushman &...
- Press release article from: PR Newswire August 23, 2000 700+ words
...two former Bristol-Myers Squibb scientists are heroes...recognized as a member of a research group that made an important...president of the Bristol-Myers Squibb Pharmaceutical Research...Institute. "Bristol-Myers Squibb prides itself on providing...
- Bristol-Myers Squibb Announces Major Advance for TAXOL (Paclitaxel) Injection...
- Press release article from: PR Newswire April 29, 1999 700+ words
...PRNewswire/ -- Bristol-Myers Squibb Company (NYSE: BMY...Cooperative Cancer Research Group. The study enrolled...president, Bristol-Myers Squibb, Oncology/Immunology...alopecia. Bristol-Myers Squibb is a diversified worldwide...
- Weill Medical College receives $500,000 Bristol-Myers Squibb grant.
- Newspaper article from: Biotech Week February 25, 2004 700+ words
...NewsRx.net) -- Bristol-Myers Squibb has awarded a 5-year $500...drug discovery at the Bristol-Myers Squibb Pharmaceutical Research Institute...the HIV virus." Moore and his research group are focusing on three major areas...
- BRISTOL-MYERS SQUIBB FILES CLAIMS AGAINST CANADIAN COMPANY FOR...
- Press release article from: PR Newswire July 5, 1995 700+ words
MONTREAL, July 5 /PRNewswire/ -- Bristol-Myers Squibb Company (NYSE: BMY) today issued the following: Bristol-Myers Squibb and Bristol-Myers Squibb Canada Inc. today announced they have filed further claims in...
- BRISTOL-MYERS SQUIBB COMPANY ANNOUNCES SALE TO TAISHO PHARMACEUT.
- News wire article from: AsiaPulse News September 16, 2009 700+ words
...MYERS-1-4)(BMY.NYSE) Bristol-Myers Squibb Company Announces Sale to Taisho Pharmaceutical...Japan) and Shares in PT Bristol-Myers Squibb Indonesia Tbk Pharmaceutical Writers...WIRE) - Sep. 16, 2009-- Bristol-Myers Squibb Company (NYSE: BMY) today announced...
- BRISTOL-MYERS SQUIBB TAKES EQUITY POSITION IN IXSYS -- WILL FUND THREE-YEAR R&D...
- Press release article from: PR Newswire June 30, 1993 700+ words
...PRNewswire/ -- Ixsys, Inc. and Bristol-Myers Squibb Pharmaceutical Group announced today...signed an agreement in which Bristol-Myers Squibb will take an equity position in Ixsys...million in funding and gives Bristol-Myers Squibb a slightly more than 9 percent equity...